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SI Text
SomeMissenseMutations at Position 277 of Ubr1 Can Affect Its in Vivo
Half-Life. This part of our study is described largely in SI Text,
because the metabolic-instability effect of Ubr1 alterations at
position 277 described below could not be linked, thus far, to
nonmutational modifications of Ubr1 at this position (see Re-
sults). To probe the functions of Ubr1 phosphorylation, each of
its 8 phosphorylated residues (Fig. 1B) was mutated to Ala, a
nonphosphorylatable small residue. The resulting Ubr1 deriva-
tives were expressed in JD55 (ubr1) S. cerevisiae from a
low-copy plasmid and the native PUBR1 promoter and terminator.
These cells also carried 1 of 2 high-copy plasmids that expressed,
via the Ub fusion technique (1, 2), X--galactosidase (X-gal)
N-end rule substrates that contained, respectively, N-terminal
Arg (a type-1 destabilizing residue) and N-terminal Tyr (a type-2
destabilizing residue) (Fig. 1A). Previous work has shown that
the enzymatic activity of gal in extracts from S. cerevisiae
expressing X-gal reporters was a reliable measure of these
reporters’ metabolic stability in vivo (1, 3). As expected, both
Arg-gal and Tyr-gal were short-lived in vivo (low levels of
gal) in the presence of wild-typeUbr1 but were long-lived in the
absence of Ubr1 (Fig. 2B). However, both Arg-gal and Tyr-
gal became long-lived in cells containing Ubr1Y277A instead of
wild-type Ubr1 (Fig. S2B). As described below, the functional
inactivity of both Ubr1Y277A and Ubr1Y277E (where Glu277 is a
‘‘mimic’’ of phospho-Tyr) (Fig. S2 B and C) stemmed largely
(possibly entirely) from their becoming short-lived in vivo, in
comparison to either wild-type Ubr1 or Ubr1Y277F, a different
missense mutant at position 277 (Fig. S2 D and E).
Dipeptides bearing type-1 or -2 destabilizing N-terminal res-
idues interact with the cognate (type-1 or -2) binding sites of
Ubr1 and thereby activate, synergistically and allosterically, the
third substrate-binding site of Ubr1. The third site mediates the
targeting of Cup9, a transcriptional repressor of a regulon that
includes the peptide transporter Ptr2 (see Introduction) (4–6).
We assayed the import of dipeptides in [ubr1 lys2] S. cerevi-
siae, a lysine (Lys)-requiring derivative of a ubr1 strain that
carried plasmids expressing either Ubr1Y277A or other mutants of
Ubr1 at position 277. [ubr1 lys2] cells expressing either
Ubr1Y277A or Ubr1Y277E were incapable of peptide import.
Specifically, these cells did not grow on plates containing mi-
cromolar levels of Lys-Ala, a phenotype indistinguishable from
that of [ubr1 lys2] cells that lacked Ubr1 and therefore
contained PTR2-repressing levels of Cup9 (Fig. S2C). In con-
trast, the same yeast strain that expressed either wild-type Ubr1
or Ubr1Y277F (containing Phe277, a nonphosphorylatable aro-
matic-residue analog of wild-type Tyr277) grew under these
conditions, implying a viability-sustaining influx of the Lys-Ala
dipeptide (Fig. S2C). Substantially higher (5 mM) levels of
Lys-Ala in the medium could partially rescue the growth of
cells expressing Ubr1Y277A but not of cells expressing
Ubr1Y277E (Fig. S2C).
As a part of this study, we produced an affinity-purified rabbit
polyclonal antibody to N-terminal half of S. cerevisiae Ubr1,
denoted as Ab1ScUBR1(1–1140) (see Results and SI Materials and
Methods). Unexpectedly, both Ubr1Y277E and Ubr1Y277A mutant
proteins were virtually undetectable by immunoblotting extracts
from the corresponding yeast strains with this antibody, in
contrast to significant levels of (identically expressed) wild-type
Ubr1 and some of its other mutants that could be detected (Fig.
S2D). These results strongly suggested that Ubr1Y277E and
Ubr1Y277A were short-lived in vivo. Pulse–chase analyses con-
firmed this conjecture, in that Ubr1Y277E was barely detectable
even immediately after the pulse, in contrast to wild-type Ubr1
or Ubr1Y277F (Fig. S2E). Because Glu at position 277 in
Ubr1Y277E was a negatively charged analog of the phospho-Tyr277
residue, these findings (Fig. S2 D and E) suggested, initially, that
phosphorylation of wild-type Ubr1 on Tyr277 may also result in
a short-lived Ubr1.
In vitro, Ubr1 appears to function as a monomer rather than,
for example, a homodimer (7, 8). To determine whether the in
vivo targeting of Ubr1Y277E for degradation was mediated, in
trans, by other molecules of Ubr1Y277E, or whether this short-
lived Ubr1 mutant was targeted by another Ub ligase, we
constructed and expressed Ubr1Y277E,C1220S, a double-missense
mutant. The previously characterized Ubr1C1220S is inactive as an
E3, but its levels in vivo are not decreased relative to those of
wild-type Ubr1 (3). In contrast to Ubr1C1220S but similarly to
Ubr1Y277E, the double-missense Ubr1Y277E,C1220S could not be
detected upon expression in either wild-type or ubr1 strains
(data not shown), indicating metabolic instability of this mutant,
despite the inactivity of Ubr1Y277E,C1220S as an E3. We concluded
that Ubr1Y277E was targeted for degradation by a non-Ubr1 Ub
ligase. To identify the relevant E2 and/or E3, we examined
degradation of Ubr1Y277E in S. cerevisiae strains that lacked
specific E2 (Ub-conjugating) enzymes. A particularly strong
stabilization of Ubr1Y277E was observed in ubc13 cells (Fig. S2
F andG). These cells lacked Ubc13, an E2 enzyme that functions
in a complex that contains Mms2 and serves as an E2 partner of
Rad5, a multifunctional protein with activities of both an E3 Ub
ligase and DNA helicase. The Ubc13-Mms2-Rad5 complex
interacts with another Ub ligase, Rad6-Rad18. The resulting
machinery orchestrates either monoubiquitylation or Lys63-
based polyubiquitylation of PCNA, a sliding clamp on DNA and
a major component of dynamic complexes that mediate DNA
replication and repair (9–13).
Ubr1Y277E, which is short-lived in wild-type S. cerevisiae (Fig.
S2D andE), was not stabilized in rad5 cells but was significantly
stabilized in mms2 cells (as well as in ubc13 cells) and also,
independently, in rad18 cells (Fig. S2 F–H). Taken together,
these results indicated that Ubr1Y277E is targeted for degradation
largely by Ub ligase complexes that involved the Ubc13-Mms2
E2 enzyme and the Rad18 E3. Yet another E2 ligand of Rad18
is Rad6 (10). The latter E2 is also an essential part of the
Ubr1-Rad6 Ub ligase of the N-end rule pathway (14, 15). Rad18
may or may not interact with Ubc13-Mms2 directly and can be
associated with it through the above-mentioned Rad5 Ub ligase
in a multifunctional and incompletely understood circuit. Al-
though our results (Fig. S2 F–H) indicate that the Ubc13-Mms2
E2 enzyme plays a role in degradation of Ubr1Y277E, it should be
noted that Ubc13-Mms2 has been known, thus far, to produce
Lys63-based polyUb chains, as distinguished from Lys48-based
chains that target a polyubiquitylated protein to the 26S pro-
teasome (10). Lys63-based polyUb chains target substrates for
fates other than proteolysis. Nevertheless, recent evidence sug-
gests that these chains can also target some proteins for degra-
dation, either by the 26S proteasome or through autophagy
(reviewed by ref. 16). In sum, we found, through the use of
mutants, that Ubr1Y277E (and most likely Ubr1Y277A as well) is
targeted for degradation by a Ub ligase that contains (at least)
Ubc13, Mms2 and Rad18 (Fig. S2 F–H).
S. cerevisiae PCNA, a sliding DNA clamp, a replication/repair
regulator, and a substrate of both Rad6-Rad18 and Ubc13-
Mms2-Rad18, is targeted, at its Lys164 residue, either by these Ub
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ligases, or by sumoylation enzymes (10, 17). The consensus
sequence of sumoylation sites isXKE, where can be Leu, Ile,
Val, or Phe, and X is any residue (18–20). Lys209 and Lys276 of
S. cerevisiae Ubr1 are parts of 2 putative sumoylation sites in the
vicinity of (phosphorylated) Tyr277. Mutational conversion of
Lys276 to Arg, which cannot be sumoylated or ubiquitylated, did
not significantly alter the in vivo levels of the resulting mutant
Ubr1 protein, whereas the level of the Ubr1K209R mutant was
significantly increased, in comparison to wild-type Ubr1 (Fig.
S2D, lanes 6, 7; compare with lane 2). However, the double-
missense Ubr1K209R,Y277E, in which the K209R mutation was
combined with the Ubr1-destabilizing Y277E mutation, re-
mained a short-lived protein in vivo (data not shown), indicating
that the bulk of metabolic instability of Ubr1Y277E did not involve
reactions at Lys209.
Metabolic Stability of Ubr1pY277 (Ubr1 Phosphorylated on Tyr277) Is
Indistinguishable From That of Bulk Ubr1. We produced, affinity-
purified and characterized 2 antibodies, Ab1ScUbr1(1–1140) and
Ab1pY277Ubr1, which recognized, respectively, all species of S.
cerevisiae Ubr1 that retained its N-terminal half and specifically
Ubr1 that had been phosphorylated on Tyr277 (Ubr1pY277) (Fig.
2 A–D). Our findings with the Ubr1Y277A and Ubr1Y277E mutants
(Fig. S2 F–H) indicated that the identity of a residue at position
277 is critical for a metabolically stable conformation of Ubr1.
These findings preceded the production of the above antibodies
and were, in fact, one reason for raising them. Surprisingly,
however, the use of Ab1ScUbr1(1–1140) and Ab1pY277Ubr1 (Fig. 2
A–D), and other approaches indicated that the metabolic sta-
bility of Ubr1pY277 (wild-type Ubr1 phosphorylated on Tyr277)
was comparable to that of the bulk wild-type Ubr1, in contrast
to short in vivo half-lives of Ubr1Y277A and Ubr1Y277E (Fig. S2 D
and E). These reproducible, intriguing but (so far) functionally
obscure results (Fig. S2 B–E) are therefore mentioned briefly
and incompletely in the main text.
Materials and Methods
Yeast Strains, Media, Genetic Techniques, and -Galactosidase Assay.
The S. cerevisiae strains used in this study are described in Table
S1. Standard techniques (21) were used for strain construction
and transformation. The strains CHY50 (pdr5::KanMX6
ubr1), CHY88 (mck1::KanMX6), CHY89 (mck1::KanMX6
ubr1), CHY201 (ubr1::KanMX6), CHY202 (ubr1::KanMX6
yck1 yck2ts), CH203 (ubr1::SkHIS3MX6), or CHY204
(ubr1::SkHIS3MX6 yck1 yck2ts) were constructed using one-
step gene replacement and PCR-derived KanMX6modules (22).
E2 and E3 mutant strains used in this study were from the
Varshavsky lab’s yeast strain collection, or were purchased from
Open Biosystems. The media for growing S. cerevisiae included
YPD medium (1% yeast extract, 2% peptone, 2% glucose; only
the most relevant media components are cited), SD medium
(0.17% yeast nitrogen base, 0.5% ammonium sulfate, 2% glu-
cose), SGal medium (0.17% yeast nitrogen base, 0.5% ammo-
nium sulfate, 2% galactose), synthetic complete (SC) medium
(0.17% yeast nitrogen base, 0.5% ammonium sulfate, 2% glu-
cose, plus a dropout mixture of compounds required by a given
auxotrophic strain), and SHM medium (0.17% yeast nitrogen
base, 0.1% allantoin, 2% glucose). Assays for -galactosidase
(gal) activity in S. cerevisiae extracts (1, 3, 23) were carried out
by using the Yeast -Galactosidase Assay Kit (Pierce), according
to the manufacturer’s protocol. The units of -galactosidase
activity were calculated as follows: unit 1000A420/[t) (v)
(A660)], where (t) and (v) were the time of incubation (min) and
the assay volume (ml), respectively.
Plasmids and Site-Directed Mutagenesis. The plasmids used in this
study are described in Table S2. pRS315(-XbaI)UBR1 is a low
copy (CEN-based) plasmid that expressed untagged wild-type
Ubr1 from the native PUBR1 promoter (3). To produce counter-
parts of this plasmid that expressed mutant Ubr1 proteins,
pRS315(-XbaI)UBR1 was digested with PstI/NotI, blunted and
self-ligated, yielding pCH100, which contained only 1 SpeI site
in theUBR1 coding region. Overlapping extension PCR (24) was
used to introduce specific mutations into the ORF of UBR1. A
pair of PCR primers, OCH61 and OCH62 (Table S3), that
flanked the region between the SpeI and PmeI sites of the UBR1
ORF, was used. Multisite Ubr1 mutants (Ubr1296A,S300A,
Ubr1S292A,S296A,S300A, Ubr1T288A,S292A,S296A,S300A, and
Ubr1Y277F,T288A,S292A,S296A,S300A) were constructed sequentially
by using specific plasmids as PCR templates: at first pCH121
(encoding Ubr1S300A), then pCH122 (encoding Ubr1S296A,S300A),
then pCH123 (encoding Ubr1S292A,S296A,S300A), and thereafter
pCH224 (encoding Ubr1T288A,S292A,S296A,S300A). Single-missense
UBR1 derivatives were constructed by using PCR primers de-
scribed in Table S3, in conjunction with complementary-
sequence primers. The resulting PCR products were digested
with SpeI/PmeI and cloned into SpeI/PmeI-cut pCH100 or
pFlagUBR1SBX (Table S2).
The high-copy pCH206 expressed, from the methionine-
repressible PMET25 promoter, the Mck1 kinase C-terminally
tagged with ha-RGSHis6 (Qiagen) an ha-His6-containing tag. To
construct pCH206, the MCK1 ORF was PCR-amplified from S.
cerevisiae genomic DNA using OCH327 and OCH372 primers
(Table S3). The resulting DNA fragment was cloned into
BamHI/XhoI-cut pRS426MET25 vector (25), yielding pCH206.
For site-directed mutagenesis of MCK1, mutations were intro-
duced into the MCK1 ORF using an approach similar to that
used for mutagenesis of Ubr1. A pair of the above PCR primers
for the cloning of pCH206 were used, in conjunctions with
primers described below and the method of overlap extension
PCR (24). For example, to construct pCH207 (Table S2), which
expressed Mck1D164A, 2 overlapping DNA fragments with a
requisite missense mutation were produced at first, using PCR
with the primer pairs OCH327/OCH353 and OCH329/OCH372
(Table S3). These fragments were then denatured and rean-
nealed, so that that they formed a partially duplex DNA that
encompassed the site of mutation and also contained 3 over-
hangs that enabled another PCR, with the primers OCH327 and
OCH372 (Table S3), that yielded the MCK1D164A ORF. DNA
fragments produced by this procedure (they encoded either
Mck1D164A or Mck1Y99F) were digested with BamHI/XhoI and
subcloned into BamHI/XhoI-cut pRS426MET25 vector, yield-
ing, respectively, pCH207 and pCH212 (Table S2).
The high-copy pCH321 plasmid expressed Yck1-myc-His7-CC
(where the myc-His7 epitopes were present immediately up-
stream of the C-terminal Cys-Cys palmitylation motif of Yck1)
from the PADH1 promoter. It was constructed as follows. The
NcoI/XhoI-cut PCR product, produced using primers OCH531
and OCH532 (Table S3) and encoding the YCK1 ORF with
epitopes as described above was subcloned into NcoI/XhoI-cut
pNTFlag717UBR1 (Table S2), replacing UBR1 of the original
plasmid with the YCK1-myc-His-7-CC ORF. pCH322 expressed
the otherwise identical Yck1-myc-His7-CC in which Lys98 was
changed to Arg. pCH322 was constructed using overlapping
PCR and the primer pairs OCH531/OCH534 and OCH533/
OCH532 (Table S3).
Construction details for other plasmids (Table S2) are avail-
able upon request. All final plasmid constructs were verified by
DNA sequencing.
Purification of Ubr1 and Mck1. The protease-deficient S. cerevisiae
SC295 that carried pFlagUBR1SBX (Table S2) (‘‘SBX’’ denotes
the presence of SalI, BamHI and XhoI sites) and overexpressed
the N-terminally f lag-tagged Ubr1 (fUbr1) (5) was grown at
30° C to A600 of 4 in 4 l of SD medium containing Trp (20
g/ml) and uracil (20 g/ml). The cells were harvested by
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centrifugation, washed once with cold PBS (PBS), and frozen in
liquid N2. Cells in a frozen pellet (20 g) were disrupted by
grinding with a pestle in mortar containing 20 ml of lysis buffer
(10% glycerol, 0.5% Nonidet P-40, 0.2 M KCl, 1 mM PMSF
(Sigma-Aldrich) (added from a freshly prepared 0.1 M stock
solution in ethanol), 10 mM NaF, 0.5 mM NaVO3, 10 mM
-glycerol phosphate, 50 mM Hepes, pH 7.5) containing pro-
tease inhibitor mixture ‘‘for use with fungal and yeast extracts’’
(Sigma-Aldrich). The suspension was centrifuged at 11,200  g
for 30 min, and the supernatant was mixed with 2 ml of anti-f lag
M2 affinity beads (Sigma-Aldrich) at 4° C for 1 h. The beads
were collected by centrifugation in Sorvall RT-600B at 1,000 rpm
for 5 min at 4°C and were washed, sequentially, with 10 ml of lysis
buffer, 10 ml of buffer A (10% glycerol, 0.5% Nonidet P-40, 1
M KCl, 1 mM EDTA, 10 mF NaF, 0.5 mM NaVO3, 10 mM
-glycerol phosphate, 50 mMHepes, pH 7.5), and 10ml of buffer
B (lysis buffer without Nonidet P-40). The anti-f lag antibody-
bound fUbr1 was eluted with buffer C (buffer B containing flag
peptide at 0.5 mg/ml) and thereafter dialyzed at 4° C overnight
against 50 mM (NH4)2CO3, pH 8.0. For Mck1-based kinase and
ubiquitylation assays, fUbr1 and fUbr1Y277F were purified as
above from the SC295, CHY89 or BY1137 strains (Table S1) that
carried either pFlagUBR1SBX or pCH119 (Table S2).
S. cerevisiae Mck1 C-terminally tagged with ha-RGSHis6 was
purified from SC295 cells that overexpressed the tagged Mck1
from pCH206 (Table S2). Expression of Mck1-ha-RGSHis6 was
induced by growing cells for 24 h at 30° C in 2 L of SD medium
containing Leu (20 g/mL) and His (20 g/mL). Cells were
collected by centrifugation, washed in cold PBS, rapidly frozen
in liquid N2, and subsequently lysed in buffer D (145 mM NaCl,
0.1% Tween 20, 5 mM imidazole, 50 mMNa-phosphate, pH 7.5)
containing protease inhibitors (10 g/mL aprotinin, 10 g/mL
leupeptin, 1 mM benzamidine, 2 g/mL pepstatin, 0.5 mM
PMSF). The lysate was passed through 2 mL of Ni-NTA beads
(50% slurry) (Qiagen) previously equilibrated in buffer D. The
beads were washed with 10 ml of buffer D and washed again with
6 ml of buffer D containing 20 mM imidazole. Mck1-ha-
RGSHis6 (or its mutant derivatives) was then eluted with 3 mL
of buffer D containing 0.2 M imidazole. These fractions were
pooled and dialyzed overnight against 2 L of buffer E (25%
glycerol, 1 mMEDTA, 50mMMes, pH 6.5). Further purification
involved chromatography of the dialyzed sample on a 5-mL
column of Mono-S Sepharose (GE Healthcare) equilibrated
with buffer E. The column was washed with 20 mL of buffer E,
and Mck1-ha-RGSHis6 (or its mutant derivatives) was eluted
with 20 mL of buffer E and a linear gradient of NaCl up to 1 M,
using FPLC. The eluted fractions were analyzed by SDS-
NuPAGE (4–12%) (Invitrogen), followed by Coomassie stain-
ing or immunoblotting with anti-HA antibody (Sigma-Aldrich).
Determination of Phosphorylation Sites in Ubr1. Purified S. cerevi-
siae fUbr1 (250 pmoles (51 g) was reduced with 2 mM DTT in
50 mM (NH4)2CO3 (pH 8.0) at 56° C for 1 h, and thereafter
alkylated with 20 mM iodoacetamide in the presence of 6M urea
(in the dark) for 45 min at room temperature. The sample (50
L) suspension was then digested with 50 L of immobilized
TPCK trypsin (Pierce) overnight at 37° C. Phosphopeptides in
the resulting sample were either enriched first, using the phos-
phopeptide isolation kit (Pierce) or were directly analyzed by
nanoscale-microcapillary reversed phase liquid chromatography
and tandem mass spectrometry (cLC-MS/MS), using the
QSTAR XL quadrupole time of flight mass spectrometer (Ap-
plied Biosystems). Phosphorylation sites were assigned by man-
ual inspection of MS/MS spectra and also using the Mascot
search engine (Matrix Science). The entire cycle of these MS-
based procedures was carried out several times, until subsequent
analyses did not yield additional phosphorylation sites.
Antibody to S. cerevisiae Ubr1. Ubr11–1140f, the C-terminally f lag-
tagged N-terminal half of the 1,950-residue wild-type S. cerevi-
siae Ubr1, was produced and purified as described (5, 15) and
was used to produce rabbit antisera (Covance). After standard
cycles of boost injections of the antigen, 10 mL of antiserum
(after the third boost) were incubated overnight at 4° C (with
gentle rocking) with 1 mL of CNBr-Sepharose (GE Healthcare)
that had been conjugated to purified full-length (flag-tagged)
fUbr1 (1 mg). The incubated suspension was loaded into a
5-mL plastic column (Pierce), letting excess liquid flow from
Sepharose beads. The column was washed with 20 mL of PBS.
Antibodies bound to fUbr1-Sepharose were eluted (in 0.5-mL
increments) with 5 mL of 0.1 M glycine (pH 2.5); the pH of
eluted factions was adjusted to 8.0 with 1 M Tris immediately
after elution. The first 6 of 0.5-mL fractions were pooled and
incubated overnight at 4° C (with gentle rocking) with 1 mL of
CNBr-Sepharose that had been conjugated to proteins of crude
extract from Ubr1-lacking JD55 (ubr1) cells, followed by the
loading onto a plastic column, as described above. The
flowthrough from that column, which contained a doubly affin-
ity-purified (both ‘‘positively’’ and ‘‘negatively’’) anti-Ubr1 an-
tibody, was incubated for 2 h at 4° C with 0.25 mL of gamma-bind
Sepharose (GE Healthcare) that contained covalently bound
Protein G. The bound antibodies were eluted with 0.1 M glycine
(pH 2.5) and immediately adjusted to pH 8.0, as described above.
Pooled fraction of eluted anti-Ubr1 were dialyzed at 4° C
overnight against PBS buffer, followed by the addition of
glycerol to the final concentration of 10%. After measuring the
concentration of protein in thus purified anti-Ubr1 antibody
sample (by measuring A280), the antibody (0.15 g/L), which
was termed Ab1ScUbr1(1–1140), was stored in multiple smaller
samples at -80° C. For immunoblotting with Ab1ScUbr1(1–1140),
preblocked Immobilon-P PVDF membrane (Millipore) was
incubated with the affinity-purified Ab1ScUbr1(1–1140) (1:2,000) in
a blocking buffer (5% nonfat milk, 0.5% Tween 20 in PBS) for
2 h, followed by standard postincubation immunoblotting pro-
cedures, with signal detection using SuperSignal Western Blot-
ting kit (Pierce).
Antibody That Recognized Ubr1pY277, Phosphorylated at Position 277.
The phosphopeptide CQFLNDLKpY277ENDY, from the se-
quence of S. cerevisiae Ubr1 shown in Fig. S2A and with the
additional N-terminal Cys residue for conjugation to the
carrier protein keyhole limpet hemocyanin, was synthesized by
Abgent, which also synthesized a nonphosphorylated counter-
part of this peptide and produced rabbit antisera to
CQFLNDLKpY277ENDY. Antibodies that bound to
CQFLNDLKpY277ENDY, were ‘‘positively’’ selected from im-
mune sera by affinity chromatography on a resin derivatized with
the above phosphopeptide immunogen. The resulting samples
were then ‘‘negatively’’ selected by passing them through a resin
derivatized with the unphosphorylated version of the same
peptide. To further increase the specificity of this antibody
sample for Ubr1 phosphorylated at Tyr277, yet another step of
‘‘negative’’ selection was used. 2 mL of the above-purified
antibody (1 mg of protein) was incubated overnight at 4° C
(with gentle rocking) with 0.25 mL of glutathione-Sepharose
(GE Healthcare) that had been conjugated to a mixture of 125
g of GST-Ubr1227–327 and 125 g of GST-Ubr1227–327,Y277F.
These fusions of GST to the Ubr1227–327 fragment (and its Y277F
mutant counterpart) were produced in Escherichia coli BL21-
CodonPlus (DE3)-RIL (Stratagene) carrying either pCH126 or
pCH127 (Table S2) and were purified using glutathione-
Sepharose gel according to the manufacturer’s protocol. The
resulting antibody, denoted as Ab1pY277Ubr1, was used to detect
Tyr277 phosphorylation of Ubr1 in yeast extracts by immuno-
blotting. The incubations were for 4 h at room temperature at the
1:1,000 dilution in 5% skin milk in PBST (PBS containing 0.5%
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Tween 20). The bound antibody was detected with a goat
anti-rabbit antibody (at 1:2,000 dilution) conjugated to horse-
radish peroxidase (HRP; Bio-Rad). The above (affinity-
purified) Ab1Y277Ubr1 antibody was produced by 1 of 2 rabbits
immunized with CQFLNDLKpY277ENDY. The other immu-
nized rabbit produced antibody that recognized both Ubr1pY277F
and unphosphorylated Ubr1. It was termed Ab2p/non-pY277Ubr1
and was used for detection of bulk Ubr1.
Preparation of Cell Extracts for Immunoblotting. In part to optimize
the preparation of yeast extracts for screening, by immunoblot-
ting, for a kinase mutant that may be defective in phosphory-
lating Ubr1 at Tyr277, we slightly modified an earlier method
(26). S. cerevisiae (Table S1) were grown to A600 of1 in SD with
additional ingredients for a strain’s auxotrophic requirements,
and the amount of cells corresponding to 1 mL at A600 of 1 was
pelleted by centrifugation at 11,200  g for 1 min. Cells were
resuspended and incubated in 1 mL of 0.2 M NaOH for 20 min
on ice or (alternatively) for 5 min at room temperature, followed
by centrifugation for 30 sec at 11,200 g. The pelleted cells were
resuspended in 50 L of HU buffer (8 M urea, 5% SDS, 1 mM
EDTA, 0.1 M DTT, 0.005% bromophenol blue, 0.2 M TrisHCl,
pH 6.8) containing 1 protease inhibitor mixture ‘‘for use with
fungal and yeast extracts’’ (Sigma-Aldrich) and heated for 10min
at 70° C. After centrifugation for 5 min at 11,200  g, 10 L of
supernatant was subjected to SDS/PAGE (4–12% NuPAGE;
Invitrogen), followed by immunoblotting with anti-f lag, anti-ha,
and antitubulin antibodies (Sigma), and also with affinity-
purified antibodies to either N-terminal half of the 225-kDa S.
cerevisiae Ubr1 or to a synthetic phospho-Tyr-containing phos-
phopeptide of Ubr1 that encompassed position 277 (Fig. S2A
and below). For yeast mutants in kinases of the Gsk3 family and
other yeast strains used in kinase screens, see Table S1. Immu-
noblotting with anti-tubulin antibody was used as a protein-
loading control, after stripping previous signal with Restore plus
Western blot stripping buffer (Pierce).
Pulse–Chase Assays. S. cerevisiae JD55 (ubr1) carrying plasmids
expressing wild-type Ubr1 (pCH100), Ubr1Y277A (pCH109),
Ubr1Y277E (pCH117), or Ubr1Y277F (pCH118) were grown at
30° C to A600 of 1 in 10 ml of SC(-Leu) medium. Cells were
pelleted by centrifugation and washed with 0.8 ml of SC medium
lacking Leu and Met. Cell pellets were gently resuspended in 0.4
ml of the same medium and labeled for 5 min at 30° C with 0.16
mCi of 35S-EXPRESS (Perkin-Elmer). Cells were pelleted again
and resuspended in 0.4 ml of SC(-Leu) containing cold 10 mM
methionine and 5 mM cysteine. Samples (0.1 ml) were taken at
the indicated time points, followed by preparation of extracts,
immunoprecipitation with affinity-purified anti-UBR1 anti-
body(1 g), SDS-NuPAGE (4–12%), and autoradiography.
In Vitro Kinase Assays. Our early attempts to identify a kinase
responsible for Ubr1 phosphorylation on Tyr277 included a ‘‘bio-
chemical’’ screen that used biotin-ERAQFLNDLKY277 ENDYM-
FDG, a biotinylated Ubr1-derived peptide substrate, and glutathi-
one transferase (GST) fusions to specific yeast kinases (27, 28). This
approach yielded Ptk2 and Tpk1. However, these kinases also
phosphorylated both GST-Ubr1227–327 and GST-Ubr1227–327,Y277F,
which were purified after their expression in E. coli (data not
shown), making it unlikely that Ptk2 or Tpk1 were the cognate
kinase(s) we sought. In a different and eventually successful ap-
proach, we used immunoblotting with the Ab1pY277Ubr1 antibody
and a library of yeast mutants in 27 putative Try kinases, as
described in the main text. The procedures described below were
used after that screen (Fig. 2 J and K), which identified Mck1 as a
cognate Ubr1 kinase.
Purified wild-type fUbr1 unphosphorylated at Tyr277 (purified
from mck1 cells; see Results) or fUbr1Y277F (which cannot be
phosphorylated at position 277) were incubated (0.1 g of Ubr1
and 0.1 g of either wild-type Mck1 or enzymatically inactive
Mck1D164A) in 20 l of kinase buffer (20 M ATP, 10 mM
MgCl2,50 mM TrisHCl, pH 7.5) containing 2 Ci of [-32P]ATP
(6,000 Ci/mmol). The reaction was stopped by adding 6 l of 4
SDS loading buffer, followed heating for 5 min at 95° C, SDS/
PAGE (4–12% NuPAGE; Invitrogen), the drying of a gel and
autoradiography, either with PhosphorImager (Molecular Dy-
namics), or with x-ray films and intensifying screen at 80° C.
Pull-down assays and in vitro kinase assays with myc-tagged
Yck1 were carried out as follows. A yeast extract (2 mg),
produced using a modification of the earlier procedure (26) (see
above) was precipitated with anti-myc antibody (Sigma) and
protein G-magnetic beads (Invitrogen) in lysis buffer (0.2 M
KCl, 1 mM EDTA, 10 mM -mercaptoethanol, 1 mM PMSF, 50
mM Hepes, pH 7.5) containing inhibitor mixture ‘‘for use with
fungal and yeast extracts’’ (Sigma-Aldrich). The beads were
washed thrice in 0.5 mL of lysis buffer that also contained 0.3 M
NaCl, and twice in kinase reaction buffer (40 M ATP, 0.1 M
NaCl, 10 mM MgCl2, 0.2 mM DTT, 50 mM TrisHCl, pH 7.5)
containing the above protease inhibitor mixture. The resulting
immunoprecipitate was resuspended in 25 L of kinase buffer
containing 4Ci of [-32P]ATP and 2.5 g of fUbr1 or GST-
Ubr1227–327 as substrates. The two substrates were purified,
respectively, from SC295 S. cerevisiae and BL21-CodonPlus
(DE3)-RIL E. coli. The reaction was performed at 30° C for 30
min and stopped by the addition of 10 l of 4SDS/PAGE
loading buffer, followed by heating 95° C for 5min; 15L of each
sample were subjected to SDS-10% PAGE, followed by Coo-
massie staining and autoradiography.
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Fig. S1. Identification of S. cerevisiae Ubr1 phosphopeptides and phosphorylation sites using cLC-MS/MS. See SI Materials and Methods. (A) Identified
phosphopeptides of Ubr1. Phosphorylated residues are in red, preceded by the prefix ‘‘p.’’ As indicated in the diagram, this approach could not distinguish
between phosphorylation at Ser292 vs. Thr291. Because the subsequently produced Ser2923Ala292 (S292A) mutation in Ubr1 abolished phosphorylation at Tyr277
(see the main text and Fig. 1C), it is very likely that the in vivo phosphorylation of Ubr1 involves Ser292. (B) Mass spectrometric analysis of a phosphopeptide
containing phospho-Tyr277 (pY277), shown as an example of cLC-MS/MS experiments. The observed molecular masses of some peaks are indicated.
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Fig. S2. Conversion of Tyr277 of S. cerevisiae Ubr1 to Ala or Glu makes the resulting Ubr1 proteins short-lived in vivo. (A) Conservation of Tyr277 and its environs
in Ubr1 proteins of fungi: S. cerevisiae (Sc), Candida glabrata (Cg), Eremothecium gossypii (Eg), and Kluyveromyces lactis (Kl). Asterisks, colons and a dot denote
identical, similar, and partially conserved residues, respectively. (B) Relative levels (enzymatic activity) of Arg-gal (filled bars) and Tyr-gal (white bars), a type-1
and a -2 N-end rule substrate, respectively (Fig. 1A), in ubr1 S. cerevisiae or in the same strain that expressed either wild-type Ubr1 or Ubr1Y277A. (C) Relative
efficiencies of dipeptide import in cells containing mutations in Ubr1 at position 277. JD55 (ubr1) cells expressing either a vector control (pRS315), or wild-type
Ubr1 (pCH100), or Ubr1Y277A (pCH109), or Ubr1Y277E (pCH117), or Ubr1Y277F (pCH118) were streaked on plates containing 110 M Lys (20 g/mL) or Lys-Ala, at
either 66M or 5 mM, followed by incubation at 30° C for 3 days. (D) Relative levels of wild-type and mutant Ubr1 proteins in JD55 (ubr1) cells expressing either
a vector control (pRS315), wild-type Ubr1 (pCH100), Ubr1Y277A (pCH109), Ubr1Y277F (pCH118), Ubr1Y277E (pCH117), Ubr1K209R (pCH157), Ubr1K276R (pCH158), or
Ubr1C1220S (pCH159). Yeast extracts were fractionated by SDS-NuPAGE (4–12%), followed by sequential immunoblotting with antibodies to Ubr1
(Ab1ScUbr1(1–1140); 1:2,000) and to tubulin (1:2,000), the latter a loading/blotting control. (E) Pulse–chase analysis of Ubr1 proteins in JD55 (ubr1) cells expressing
either wild-type Ubr1 (pCH100), Ubr1Y277A (pCH109), Ubr1Y277E (pCH117), or Ubr1Y277F (or pCH118). Cells were labeled for 5 min with [35S]methionine/cysteine,
followed by a chase for 10 and 30 min, immunoprecipitation of cell extracts with the anti-Ubr1 antibody Ab1ScUbr1(1–1140), SDS-6% PAGE, and autoradiography
using PhosphorImager (1). (F) Degradation of Ubr1Y277E involves pathways that involve Ubc13, Mms2 and Rad18. S. cerevisiae strains that carried pCH135 (which
expressed flag-tagged Ubr1Y277E) and were null in specific Ub-conjugating (E2) enzymes were grown to A600 of 1 in SC(-Leu) medium and treated with
cycloheximide (50 g/ml) for indicated times. Cell extracts were subjected to SDS-NuPAGE (4–12%) and immunoblotting with anti-flag (Upper) and antitubulin
antibodies, the latter being a loading control. (G) Same as in F, with wild-type (BY4741), ubc13 (an experiment independent from the one in F) and mms2
strains. (H) Same as in F, with rad5 and rad18 strains (Table S1).
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Fig. S3. C-terminal region of the 1,950-residue S. cerevisiae Ubr1 is required for Ubr1 phosphorylation on the N terminus-proximal Tyr277 residue. (A) Extracts
from JD55 (ubr1) cells that expressed Ubr1 or its C-terminally truncated derivatives were immunoblotted with the Ab1pY277Ubr1 antibody, specific for Ubr1
phosphorylated on Tyr277 (pY277; Top); with the Ab2p/non-pY277Ubr1 antibody (Middle) that recognized both Ubr1pY277 and Ubr1 that was unphosphorylated on
Tyr277 (see SI Materials and Methods), and with antitubulin antibody (Bottom), the latter a loading control. Lane 1, vector alone. Lane 2, Ubr11–717
(pNT717FlagUBR1; see Table S2). Lane 3, Ubr11–1140 (pUBR1NT1140Flag). Lane 4, Ubr11–1367 (pFlagUBR1NT1367). Lane 5, Ubr11–1700 (pFlagUBR1NT1700). Lane 6,
Ubr11–1818 (pFlagUBR1NT1818). Lane 7, wild-type Ubr1 (pFlagUBR1SBX). (B) SDS-NuPAGE (4–12%) of purified Mck1, with staining by Coomassie. Lane 1,
molecular mass markers. Lane 2, purified Mck1-ha-RGSHis6 (see SI Materials and Methods).
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Fig. S4. (A) Identification of Mck1 as a cognate kinase for Ubr1 phosphorylation on Tyr277. S. cerevisiae strains lacking specific Tyr kinases (Table S1) were
transformed with fUbr1-expressing pFlagUBR1SBX (Table S2). Cultures were grown in SC(-Leu) medium to A600 of1, followed by SDS/PAGE of cell extracts and
sequential immunoblotting with Ab1pY277Ubr1 and anti-flag antibodies. (B) BY1137 (mck1) cells carried pFlagUBR1SBX (expressing wild-type fUbr1) and either
pRS426MET25 (vector; lane 1), or pCH206 (expressing wild-type Mck1; lane 2), or pCH207 (expressing Mck1D164A; lane 3), or pCH212 (expressing Mck1Y199F; lane
4). Cultures were grown to A600 of 1 in SC(-Leu,-Ura), followed by processing of extracts for SDS-NuPAGE (4–12%) and sequential immunoblotting with
Ab1pY277Ubr1, anti-flag, and anti-HA antibodies (the latter were used with a lower part of PVDF membrane, because of large size differences between Mck1 and
Ubr1). (C) Coimmunoprecipitation of Ubr1 and Yck1. Lane 1, 0.25% input of extract that was used for immunoprecipitation. Extracts from JD55 (ubr1) cells
expressing fUbr1 and Yck1-myc were incubated with beads only (lane 2) or with anti-Ubr1 (Ab1ScUbr1(1–1140)) prebound to beads (lane 3). Bound proteins were
analyzed by SDS-NuPAGE (4–12%) and immunoblotting with anti-flag and anti-myc antibodies. (D) Same as in C but extracts were incubated with beads only
(lane 2) or anti-myc antibody prebound to beads (lane3) before SDS/PAGE and (parallel) immunoblotting with anti-flag and anti-myc antibodies, after cutting
PVDF membrane into upper (Ubr1) and lower (Yck1) parts. Lane 1, 0.25% input of extract for immunoprecipitation. (E) Ubr1 is phosphorylated by Yck1. Extracts
from JD55 (ubr1) cells expressing Yck1-myc or Yck1K98R-myc were incubated with beads only (lane 1) or with anti-myc antibody prebound to beads (lanes 2 and
3), followed by incubation of resuspended precipitate with-[32]ATP, SDS-NuPAGE (4–12%), electrophoretic transfer to PVDF membrane, autoradiography (Top),
immunoblotting with anti-myc antibody (Bottom), and staining with Coomassie (Middle; showing the band of Ubr1). (F) GST-Ubr1227–327 and GST-Ubr1227–327,
S300A fusion proteins were expressed in E. coli and purified as described in SI Materials andMethods. Purified GST-Ubr1227–327, GST-Ubr1227–327, S300A or GST alone
were incubated with the immunoprecipitated Yck1-myc (lane 1) or catalytically inactive Yck1K98R-myc (lane 2) for 30 min at 30° C, followed by SDS/PAGE, staining
of proteins by Coomassie (Middle) and autoradiography (Top and Bottom). Top and Bottom are 32P autoradiograms in the molecular-mass regions of,
respectively, GST and GST-Ubr1 fusions, and of Yck1/2. (G) S300A mutation in Ubr1 inhibits the Trp-induced, Ubr1-dependent acceleration of Cup9 degradation.
S. cerevisiae CHY203 (ubr1) carrying pRS416MET25CUP9NSF and either pCH100 or pCH114 (Table S2) were grown to A600 of0.8 at 25° C in SD medium without
amino acids, and thereafter incubated further in SD plus Trp (1 mM) for 30 min, followed by SDS-NuPAGE (4–12%) and immunoblotting of extracts with anti-flag
(to detect Cup9NSF) and anti-tubulin antibodies, the latter a loading/blotting control.
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Table S1. S. cerevisiae strains used in this study
Strains Relevant genotypes Sources
JD52 MATa trp1- 63 ura3–52 his3- 200 leu2–3112. lys2–801 Ref. 1
JD55 ubr1::HIS3 in JD52 Ref. 1
CHY50 pdr5::KanMX6 in JD55 This study
CHY88 mck1::KanMX6 in JD52 This study
CHY89 mck1::KanMX6 in JD55 This study
SC295 MATa ura3–52 leu2–3,112 regl-501 gall pep4–3 Ref. 2
RJD347 MAT ura3–52 Laboratory collection
AVY26 ubr1::hisG in RJD347 Laboratory collection
LRB906 MATa YCK1 YCK2 his3 leu2 ura3 Ref. 3
LRB756 MATa his3 leu2 ura3–52 yck1–1::ura3 yck2–2ts Ref. 3
CHY201 ubr1::KanMX6 in LRB906 This study
CHY202 ubr1::KanMX6 in LRB756 This study
CHY203 ubr1::SkHIS3MX6 in LRB906 This study
CHY204 ubr1::SkHIS3MX6 in LRB756 This study
K601 wild-type W303–1A Ref. 4
K1305 mck1::HIS3 in K601 Ref. 4
ZH35 mck1::TRP1 mrk1 rim11:HIS3 Ref. 4
ZH38 mck1::TRP1 mrk1 rim11::HIS3 ygk3::LEU2 in K601 Ref. 4
ZH39 mck1::TRP1 rim11::HIS3 ygk3::LEU2 in K601 Ref. 4
ZH40 mck1::TRP1 mrk1 ygk3::LEU2 in K601 Ref. 4
ZH45 mrk1 rim11::HIS3 ygk3::LEU2 in K601 Ref. 4
BY4741 MATa his3–1 leu2–0 met15–0 ura3–0 Open Biosystems
BY6589 bub1::KanMX4 in BY4741 Open Biosystems
BY1428 cka1::KanMX4 in BY4741 Open Biosystems
BY5693 cmk1:: KanMX4 in BY4741 Open Biosystems
BY7028 ctk1:: KanMX4 in BY4741 Open Biosystems
BY6774 ctk2:: KanMX4 in BY4741 Open Biosystems
BY6512 ctk3:: KanMX4 in BY4741 Open Biosystems
BY3798 dun1:: KanMX4 in BY4741 Open Biosystems
BY4341 gin4:: KanMX4 in BY4741 Open Biosystems
BY1317 ime2:: KanMX4 in BY4741 Open Biosystems
BY1907 ire1:: KanMX4 in BY4741 Open Biosystems
BY2489 kin4:: KanMX4 in BY4741 Open Biosystems
BY1507 kns1:: KanMX4 in BY4741 Open Biosystems
BY1137 mck1:: KanMX4 in BY4741 Open Biosystems
BY2487 mkk1:: KanMX4 in BY4741 Open Biosystems
BY2112 mkk2:: KanMX4 in BY4741 Open Biosystems
BY3776 mrk1::KanMX4 in BY4741 Open Biosystems
BY7101 pbs2:: KanMX4 in BY4741 Open Biosystems
BY4525 rck1:: KanMX4 in BY4741 Open Biosystems
BY5157 rck2:: KanMX4 in BY4741 Open Biosystems
BY6745 rim11:: KanMX4 in BY4741 Open Biosystems
BY802 sky1:: KanMX4 in BY4741 Open Biosystems
BY3857 ste7:: KanMX4 in BY4741 Open Biosystems
BY7006 yak1:: KanMX4 in BY4741 Open Biosystems
BY1963 yck1:: KanMX4 in BY4741 Open Biosystems
BY2058 yck2:: KanMX4 in BY4741 Open Biosystems
BY6122 yck3:: KanMX4 in BY4741 Open Biosystems
BY6278 ygk3::KanMX4 in BY4741 Open Biosystems
BY1435 yil042c:: KanMX4 in BY4741 Open Biosystems
BY5021 ykl171w:: KanMX4 in BY4741 Open Biosystems
BY2797 pho85:: KanMX4 in BY4741 Open Biosystems
BY4425 ubc2:: KanMX4 in BY4741 Open Biosystems
BY3216 ubc4:: KanMX4 in BY4741 Open Biosystems
BY3994 ubc5::KanMX4 in BY4741 Open Biosystems
BY597 ubc7::KanMX4 in BY4741 Open Biosystems
BY6577 ubc8:: KanMX4 in BY4741 Open Biosystems
BY4763 ubc10:: KanMX4 in BY4741 Open Biosystems
BY1636 ubc11:: KanMX4 in BY4741 Open Biosystems
BY5214 ubc12:: KanMX4 in BY4741 Open Biosystems
BY4027 ubc13:: KanMX4 in BY4741 Open Biosystems
BY4454 mms2:: KanMX4 in BY4741 Open Biosystems
BY3771 bre1:: KanMX4 in BY4741 Open Biosystems
BY6430 rad5:: KanMX4 in BY4741 Open Biosystems
BY5787 rad18:: KanMX4 in BY4741 Open Biosystems
1. Ghislain M, Dohmen RJ, Levy F, Varshavsky A (1996) Cdc48p interacts with Ufd3p, a WD repeat protein required for ubiquitin-mediated proteolysis in Saccharomyces cerevisiae. EMBO
J 15:4884–4899.
2. Du F, Navarro-Garcia F, Xia Z, Tasaki T, Varshavsky A (2002) Pairs of dipeptides synergistically activate the binding of substrate by ubiquitin ligase through dissociation of its
autoinhibitory domain. Proc Natl Acad Sci USA 99:14110–14115.
3. Babu P, et al. (2002) Plasma membrane localization of the Yck2p yeast casein kinase 1 isoform requires the C-terminal extension and secretory pathway function. J. Cell. Sci. 115,
4957–4968.
4. Hilioti Z, et al. (2004) GSK-3 kinases enhance calcineurin signaling by phosphorylation of RCNs. Genes Dev 18:35–47.
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Table S2. Plasmids used in this study
Plasmids Descriptions Sources
pRS315(-XbaI)UBR1 Ubr1 in pRS315 Ref.1
pFlagUBR1SBX fUbr1 in YEplac181, with PADH1 promoter and TCYC1 terminator Ref. 2
pNTFlag717UBR1 fUbr11–717 in YEplac181, with PADH1 promoter Ref. 2
pUBR1NT1140Flag Ubr11–1140f in pFlagUBR1SBX Ref. 2
pFlagUBRNT1367 fUbr11–1367 in pFlagUBR1SBX Ref. 2
pFlagUBR1NT1700 fUbr11–1700 in pFlagUBR1SBX Ref. 2
pFlagUBR1NT1818 fUbr11–1818 in pFlagUBR1SBX Ref. 2
pSOB33 Ubr1 in YEp352 Ref. 3
pSS4 PPTR2-LacZ in YCp50 Laboratory collection
pMET416CUP9NSF Cup9NSF in pRS416MET25 Laboratory collection
pMET416FUPRCUP9NSF Flag-DHFR-UbK48R-Cup9NSF in pRS416MET25 Ref. 4
pRS426MET25 pRS426, with PMET25 promoter and TCYC1 terminator Ref. 5
pGEX4T-3 N-terminal GST tag fusion plasmid GE Healthcare
pFA6a-KanMX6 KanMX6 cassette Ref. 6
pFA6a-SkHIS3MX6 SkHIS3 cassette Ref. 6
pCH100 pRS315(-XbaI)UBR1 that was SmaI/NotI-cut, blunted and ligated This study
pCH109 Ubr1Y277A in pCH100 This study
pCH114 Ubr1S300A in pCH100 This study
pCH117 Ubr1Y277E in pCH100 This study
pCH118 Ubr1Y277F in pCH100 This study
pCH119 Ubr1Y277F in pFlagUBR1SBX This study
pCH120 Ubr1S296A in pFlagUBR1SBX This study
pCH121 Ubr1S300A in pFlagUBR1SBX This study
pCH122 Ubr1S296A,S300A in pFlagUBR1SBX This study
pCH123 Ubr1S292A ,S296A,S300A in pFlagUBR1SBX This study
pCH126 Ubr1227–327 fragment in pGEX4T-3 This study
pCH127 Ubr1227–327,Y277F in pCH126 This study
pCH129 Ubr1227–327, S300A in pCH126 This study
pCH135 Ubr1Y277E in pFlagUBR1SBX This study
pCH157 Ubr1K209R in pCH100 This study
pCH158 Ubr1K276R in pCH100 This study
pCH159 Ubr1C1220S in pCH100 This study
pCH206 Mck1-ha-RGSHis6 in pRS426MET25 This study
pCH207 Mck1D164A in pCH206 This study
pCH212 Mck1Y199F in pCH206 This study
pCH214 Ubr1T288A in pFlagUBR1SBX This study
pCH217 Ubr1S292A,S296A,S300A in pFlagUBR1SBX This study
pCH223 Ubr1S292A in pFlagUBR1SBX This study
pCH224 Ubr1T288A,S292A,S296A, S300A in pFlagUBR1SBX This study
pCH246 Ubr1S300D in pCH100 This study
pCH321 Yck1-myc-His7-CC in YEplac181 with PADH1 promoter TCYC1 terminator This study
pCH322 Yck1K98R in pCH321 This study
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Table S3. Some of PCR primers used in this study
Name Sequence
OCH38 Ubr1S296A: 5’-AAC AAC AGC AAA GAC GGC CCC CTC TAA TAG CCC TG-3’
OCH40 Ubr1S96A: 5’-CGA GCC CCT CTA ATG CCC CTG AGG CAT CTC C-3’
OCH42 Ubr1S300A: 5’-GCC CTG AGG CAG CTC CAT CGC TTG C-3’
OCH50 Ubr1Y277A: 5’-GCG CAG TTT TTA AAC GAT TTA AAA GCT GAA AAC GAT TAT ATG TTT GAC GGA-3’
OCH61 Ubr1F: 5’-AAC CCT TGT ATA GGT GTC-3’
OCH62 Ubr1R: 5’-CTG AAA TAT TTC TCC ACC-3’
OCH63 Ubr1S292A,S300A: 5’-CGA GCC CCT CTA ATG CCC CTG AGG CAG CT-3’
OCH65 Ubr1S292A,S296A,S300A: 5’-AAC AAC AGC AAA GAC GGC CCC CTC TAA TGC CCC-3’
OCH75 Ubr1Y277E: 5’-GCG CAG TTT TTA AAC GAT TTA AAA GAA GAA AAC GAT TAT ATG TTT GAC GGA AC-3’
OCH77 Ubr1Y277F: 5’-GCG CAG TTT TTA AAC GAT TTA AAA TTT GAA AAC GAT TAT ATG TTT GAC GGA-3’
OCH278 Ubr1K209R: 5’-TGA ATC ATT CCA TAC ATC TTC TTC TCT TAT GTC GGC ATT TGT GGC GGG ATC-3’
OCH279 Ubr1K276R: 5’-GTC AAA CAT ATA ATC GTT TTC ATA TCT TAA ATC GTT TAA AAA CTG CGC TCT-3’
OCH327 Mck1F: 5’-CTA GGATCC ATGTCTACGG AAGAGCAGAA TGGT-3’
OCH329 Mck1D164AF: 5’-GGT CTT GGC GTT TGT CAT CGT GCT ATC AAA CCA TCC AAT GTT CTT-3’
OCH330 Mck1Y199F: 5’-CAT AAC CAG CCT TCA ATT AGT TTT ATC TGT TCA AGA TTT TAT AGA-3’
OCH338 Ubr1T288A: 5’-GAT TAT ATG TTT GAC GGA ACA ACA GCA GCA AAG ACG AGC CCC TCT AAT AGC-3’
OCH353 Mck1D164AR: 5’-AAG AAC ATT GGA TGG TTT GAT AGC ACG ATG ACA AAC GCC AAG ACC-3’
OCH372 Mck1F: 5’-AAA CTC GAG TTA GTG ATG ATG GTG ATG ATG AGA ACC TCT AGC GTA
ATC TGG AAC ATC GTA TGG GTA TTC AGC AAC TTT CGT AGG TTT AAT-3’
OCH531 Yck1F: 5’-ACA CCATGGGT ATGTCCATGC CCATAGCAAG TACC-3’
OCH532 Yck1R: 5’-AAA CTC GAG TTA GTG ATG ATG GTG ATG ATG GTG AGAACC TCT CAG ATC
TTC TTC AGA AAT AAG TTT TTG TTC ACC TAA TTT TTG GAA AAA GCC CTT-3’
OCH533 Yck1K98RF:3’-AAT GGC GTA CCC GTC GCG ATC AGA TTC GAG CCC AGA AAA ACG GAG-3’
OCH534 Yck1K98RR: 5’-CTC CGT TTT TCT GGG CTC GAA TCT GAT CGC GAC GGG TAC GCC ATT-3’
F and R denote forward and reverse primers.
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